Gotham Asset Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-16,467
Closed -$454K 1156
2021
Q2
$454K Buy
16,467
+7
+0% +$138 0.02% 709
2021
Q1
$271K Buy
+16,460
New +$375K 0.01% 875

Gotham Asset Management's TBIO Position: Q3 2021 in Review

Gotham Asset Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 16,467 shares — an estimated $454K sold.

Gotham Asset Management first reported a position in TBIO in Q1 2021 and held it in 2 quarters. The position peaked at $454K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Gotham Asset Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Gotham Asset Management sold 16,467 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $454K.
  • Gotham Asset Management first reported a position in Translate Bio, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Gotham Asset Management's Translate Bio, Inc. Common Stock position peaked at $454K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Gotham Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.